Universal Health Services Inc. ($UHS) Stock Forecast: Up 5.1% Today

What is Universal Health Services Inc.?

Universal Health Services (UHS) is a leading healthcare management company that operates through its subsidiaries acute care hospitals, behavioral health facilities, and ambulatory centers. The company focuses on providing high-quality patient care and innovative treatment solutions in the healthcare sector.

Why is Universal Health Services Inc. going up?

UHS stock is up 5.1% on Feb 5, 2026 20:12

• UHS experienced a strong bullish movement today, likely driven by positive market sentiment and investor confidence in the company's growth prospects.
• The focus on sales growth as a reliable indicator of underlying momentum and potential for future earnings aligns with UHS's strategic direction, reinforcing investor belief in the company's ability to deliver strong financial results.
• The leadership reset and activist pressure on competitor Acadia Healthcare (ACHC) may have also indirectly benefited UHS, as investors seeking stability and strategic actions in the healthcare sector may have turned to UHS as a more promising investment option.

UHS Price Chart

UHS Technical Analysis

UHS News

Community Health Systems Closes $600 Mn Tennessee Hospital Sale to VUMC

Community Health Systems (CHS) has completed the sale of its 80% ownership in two joint ventures to Vanderbilt University Medical Center (VUMC) for $623 million. This transaction grants VUMC full ownership of Tennova Healthcare–Clarksville and related facilities, expanding its regional presence in one of Tennessee's fastest-growing cities. VUMC plans to rename the hospital, increase staffing, and recruit additional physicians to enhance specialty services.

https://www.digitalhealthnews.com/community-health-systems-closes-600-mn-tennessee-hospital-sale-to-vumc

Zacks.com featured highlights include Universal Health Services, Pinnacle West Capital and Methanex

The article highlights Universal Health Services (UHS), Pinnacle West Capital (PNW), and Methanex (MEOH) as top stock picks for robust sales growth in 2026. It emphasizes sales growth as a more reliable indicator than earnings, reflecting real demand and potential for future earnings. All three companies currently hold a Zacks Rank #2, with projected sales growth rates of 5.2% for UHS, 4.6% for PNW, and 9.8% for MEOH.

https://finance.yahoo.com/news/zacks-com-featured-highlights-universal-152600638.html

Zacks.com featured highlights include Universal Health Services, Pinnacle West Capital and Methanex

This article highlights three companies – Universal Health Services (UHS), Pinnacle West Capital (PNW), and Methanex (MEOH) – identified by Zacks as strong sales growth stocks for 2026. The focus is on sales growth as a more reliable indicator of a company's underlying momentum than earnings. Each company's services, expected sales growth rate for 2026, and Zacks Rank are detailed, recommending them for robust returns.

https://www.nasdaq.com/articles/zackscom-featured-highlights-include-universal-health-services-pinnacle-west-capital-and

Zacks.com featured highlights include Universal Health Services, Pinnacle West Capital and Methanex

Zacks Equity Research has highlighted Universal Health Services, Inc. (UHS), Pinnacle West Capital Corp. (PNW), and Methanex Corp. (MEOH) as top sales growth stocks for robust returns in 2026. The article emphasizes sales growth as a more reliable indicator than earnings, reflecting real demand and potential for future earnings. All three companies currently hold a Zacks Rank #2, showcasing strong expected sales growth for the year.

https://sg.finance.yahoo.com/news/zacks-com-featured-highlights-universal-152600638.html

Acadia Healthcare Leadership Reset And Activist Pressure Refocus Investor Attention

Acadia Healthcare (NASDAQ:ACHC) has reappointed Debra K. Osteen as CEO following the departure of Christopher H. Hunter, amidst activist investor Engine Capital's call for a strategic review including a potential sale or significant share buybacks. The company's stock has seen substantial declines, dropping 70.5% over the past year and 83.5% over three years, intensifying pressure on the board to improve returns. Osteen's return, coupled with activist involvement, suggests a focus on operational stability and strategic actions to address financial performance.

https://simplywall.st/stocks/us/healthcare/nasdaq-achc/acadia-healthcare/news/acadia-healthcare-leadership-reset-and-activist-pressure-ref

Trending Today

Estee Lauder Companies Inc. (The) ($EL) Stock Forecast: Down 18.7% Today

Coinbase Global Inc. ($COIN) Stock Forecast: Down 13.6% Today

Cummins Inc. ($CMI) Stock Forecast: Down 11.0% Today

Qualys Inc. ($QLYS) Stock Forecast: Down 1.2% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.0% Today

QUALCOMM Incorporated ($QCOM) Stock Forecast: Down 9.8% Today

SolarEdge Technologies, Inc. ($SEDG) Stock Forecast: Down 6.6% Today

National Oilwell Varco Inc. ($NOV) Stock Forecast: Down 5.1% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 14.7% Today

Dogecoin ($DOGE) Crypto Forecast: Down 14.5% Today

Universal Health Services Inc. Price History

28.09.2025 - UHS Stock was up 3.4%

• UHS stock reached a 52-week high today, surpassing Q3 earnings and revenue estimates, and demonstrating fast-paced momentum.
• The company's strong performance can be attributed to consistently beating earnings estimates, impressive fundamentals, and being attractively priced for investors.
• Investor optimism about UHS's future potential is evident from the positive reactions to its financial results and growth prospects.
• The market movement reflects confidence in UHS's ability to deliver strong performance and maintain its growth trajectory in the healthcare industry.

31.11.2025 - UHS Stock was down 2.8%

• The bearish movement in UHS stock today can be attributed to several factors:
• Texas Permanent School Fund Corp significantly reducing its stake in UHS by 59.8% in Q2 might have signaled to other investors a lack of confidence in the company's future prospects.
• Despite the strong quarterly earnings report, the consensus rating of "Hold" by brokerages and the mixed price targets could have led to uncertainty among investors, causing some to sell off their positions.
• The increase in institutional ownership, with Osaic Holdings Inc. acquiring a substantial number of shares, could indicate conflicting sentiments within the market, leading to a lack of clear direction for the stock price.
• The focus on key financial metrics by health system leaders may have also influenced investor sentiment towards healthcare companies like UHS, especially in a dynamic and competitive industry landscape.

24.09.2025 - UHS Stock was up 1.7%

• Impressive Q3 earnings were reported by UHS, surpassing expectations and boosting investor confidence in the company's performance.
• Focusing on key metrics in the earnings report provided a deeper insight into UHS's operational efficiency and financial health, further supporting the bullish market movement.
• Investors are optimistic about UHS's potential growth and performance, leading to increased buying interest and driving the stock price higher.

29.06.2025 - UHS Stock was up 5.2%

• UHS stock experienced a bullish movement.
• The company reported strong Q2 earnings, surpassing earnings per share (EPS) and revenue estimates.
• Despite concerns about the behavioral health segment, UHS raised its FY25 EPS guidance and EBITDA forecast, showing positive growth prospects.
• The market reacted positively to the earnings and guidance, leading to the bullish movement in UHS stock.

24.06.2025 - UHS Stock was down 5.1%

• UHS experienced a bearish movement today, possibly due to concerns about rising costs impacting earnings despite potential gains from hospital and behavioral health services.
• The market may be reacting to uncertainties surrounding UHS' Q2 earnings report, with investors cautious about the company's ability to maintain profitability amidst increasing expenses.
• Despite positive aspects like gains from healthcare services, the overshadowing effect of escalating costs could be driving the bearish sentiment in UHS' stock price today.

07.00.2026 - UHS Stock was down 5.0%

• The Outpatient Clinics Market is set to expand, potentially signaling heightened competition in the healthcare sector.
• A federal judge's ruling pausing the new 340B drug rebate program might have impacted UHS's revenue outlook.
• Despite solid quarterly earnings, institutional selling by Virginia Retirement Systems Et Al could have played a role in the stock's downturn.
• UHS's weaker performance against competitors during a general market decline indicates specific internal factors affecting its stock value.

07.00.2026 - UHS Stock was down 7.0%

• The bearish movement in UHS stock could be attributed to concerns over the potential non-extension of Affordable Care Act subsidies, leading to a cut in fiscal year 2026 adjusted EBITDA estimates.
• Despite the lowered price target, there is still an upside potential of 11%, indicating some optimism in the stock.
• The projected boom in the Outpatient Clinics Market could indirectly impact UHS as it operates in the healthcare sector, potentially creating competitive pressures or shifting dynamics within the industry.
• Discussion around debt management strategies in the healthcare sector might influence investor sentiment towards companies like UHS with regards to their balance sheet strength.

16.06.2025 - UHS Stock was down 5.2%

• Wall Street analysts have predicted a potential upside of 28% for UHS, but the stock experienced a bearish movement today.
• The discrepancy between the positive long-term performance of UHS and the current bearish trend could be attributed to short-term market fluctuations or unexpected news impacting investor sentiment.
• Investors may be reacting to factors beyond the long-term growth potential of the company, such as macroeconomic conditions or industry-specific challenges.
• It is essential for traders to consider both short-term market movements and long-term performance indicators when making investment decisions in stocks like UHS.

29.09.2025 - UHS Stock was up 5.4%

• UHS saw a significant 53% year-over-year surge in earnings per share in Q3, fueled by higher admissions and improved patient days, leading to a positive reaction from investors.
• Management's decision to increase its 2025 EPS forecast to $21.50-$22.10 has enhanced trust in UHS's future outlook.
• UHS exceeded Q3 earnings and revenue expectations by a sizable margin, demonstrating robust operational performance and financial stability, likely driving the stock's upward trend.
• Despite reaching a 52-week high, UHS remains attractively priced, making it an appealing option for investors seeking stocks with strong momentum at reasonable valuations.

29.06.2025 - UHS Stock was up 3.8%

• UHS surpassed Q2 earnings and revenue estimates by +10.31% and +1.51% respectively, showcasing robust financial performance.
• The company's gains from hospital and behavioral health services were key drivers of its positive results.
• Although there were worries about increasing costs impacting earnings, UHS outperformed expectations, prompting the bullish market trend.
• Investors hold a positive outlook on UHS's future potential, buoyed by its strong Q2 showing and anticipated growth in critical metrics.

05.01.2026 - UHS Stock was up 5.1%

• UHS experienced a strong bullish movement today, likely driven by positive market sentiment and investor confidence in the company's growth prospects.
• The focus on sales growth as a reliable indicator of underlying momentum and potential for future earnings aligns with UHS's strategic direction, reinforcing investor belief in the company's ability to deliver strong financial results.
• The leadership reset and activist pressure on competitor Acadia Healthcare (ACHC) may have also indirectly benefited UHS, as investors seeking stability and strategic actions in the healthcare sector may have turned to UHS as a more promising investment option.

22.06.2025 - UHS Stock was down 1.5%

• Today's downward movement in UHS stock could be due to investors taking profits following a period of notable growth.
• While Wall Street analysts have highlighted the company's growth prospects, market dynamics or industry-related updates may have prompted the sell-off.
• It is possible that market participants reacted to overall market shifts or specific company-related developments that raised uncertainties about UHS's future performance.
• Traders may be reassessing their UHS positions in light of short-term market changes or external factors impacting the healthcare sector.